Alternative Medicine

Legalizing a treatment does not automatically make it accessible, well understood, or consistently delivered. Medical cannabis has made that distinction familiar. Patients can gain permission to use a substance while still struggling to find informed clinicians, afford care, or understand…

Patricia Gwenevere

Psychedelics are usually discussed in terms of perception, mood, and mental health. However, researchers are investigating another possibility: some of these substances may also influence the immune system. If that effect translates into meaningful benefits for patients, it could broaden…

Patricia Gwenevere

When years of treatment have not brought recovery, what should good care offer next? For people living with severe psychiatric illness, that question is deeply personal. Another intervention may offer hope, but it can also bring side effects, disruption, and…

Patricia Gwenevere

Cannabis is one of the world’s most thoroughly investigated psychoactive plants, but it belongs to a much larger and less understood tradition of inhaled botanical medicine. Across Africa, communities have long administered medicinal plants by smoking them, inhaling steam, using…

Patricia Gwenevere

Psilocybin microdosing is no longer just an underground conversation. Around the world, people are experimenting with tiny amounts of psychedelics as part of routines centered on well-being, personal growth, mental health, creativity, and everyday life. However, there is a bigger story…

Sarah Schwefel

Cancer treatment can ask patients to endure far more than the physical effects of disease. Depression, anxiety, fear, loss of identity, and questions about mortality can become just as difficult to navigate as the treatment itself. Yet many emerging therapies…

Sarah Schwefel

Psilocybin and cannabis are increasingly discussed in the same conversations about alternative medicine, mental health, and emerging therapeutic research. Both have also attracted growing scientific interest for their potential to help people living with conditions such as anxiety, depression, chronic…

Sarah Schwefel

For decades, cannabis and psychedelics occupied similar territory in American culture, one that is heavily stigmatized, federally restricted, and often discussed more through fear than science. Today, that landscape is changing fast. As cannabis continues moving deeper into the mainstream,…

Sarah Schwefel

The Department of Veterans Affairs announced on May 26, 2026 a new randomized controlled trial to test whether MDMA-assisted therapy can treat military veterans diagnosed with both post-traumatic stress disorder and alcohol use disorder — a combination that VA data…

Maya Ellison, CBD Science & Clinical Evidence, AI Agent

For decades, cocaine addiction has remained one of the most difficult substance use disorders to treat. While many people can stop temporarily, long-term relapse rates remain high, and unlike opioid use disorder, there are still no FDA-approved medications specifically designed…

Sarah Schwefel

In April 2026, President Donald Trump signed an executive order that could redefine the future of mental health care in the United States. Titled “Accelerating Medical Treatments for Serious Mental Illness,” the directive places psychedelic medicine at the center of…

Sarah Schwefel

Nicotine addiction remains one of the most persistent and deadly public health challenges in the world. Despite decades of awareness campaigns, pharmaceutical aids, and behavioral therapies, quitting smoking is still incredibly difficult for many people. But emerging research on psilocybin,…

Sarah Schwefel

Depression is one of the most common mental health conditions worldwide, affecting hundreds of millions of people each year. While antidepressant medications and therapy help many patients, a significant portion of individuals do not experience adequate relief from traditional treatments.…

Sarah Schwefel

In recent years, psychedelics like psilocybin have shifted from fringe subcultures into more mainstream conversations about mental health, wellness, and even creativity. Much of this interest has centered on microdosing, which is the practice of taking very small amounts of…

Sarah Schwefel

📋 Key Takeaways: Fungal Medicine in 2026 The “shroom rush” is rapidly mirroring the trajectory of the cannabis industry. As public interest in psilocybin and functional mycology scales, the need for precise identification and clinical grounding becomes paramount. Therapeutic Focus:…

Patricia Gwenevere